| Ident. | Authors (with country if any) | Title |
|---|
| 000007 (2011) |
Jose Luis L Pez-Send N [Espagne] ; Ana Royuela [Espagne] ; Patricia Trigo [Espagne] ; Michael Orth [Allemagne] ; Herwig Lange [Allemagne] ; Ralf Reilmann [Allemagne] ; Jennifer Keylock [Royaume-Uni] ; Hugh Rickards [Royaume-Uni] ; Silvia Piacentini [Italie] ; Ferdinando Squitieri [Italie] ; Bernhard Landwehrmeyer [Allemagne] ; Marie-Noelle Witjes-Ane [Pays-Bas] ; Caroline. K. Jurgens [Pays-Bas] ; Raymund. A. C. Roos [Pays-Bas] ; Victor Abraira [Espagne] ; Justo. G. De Yébenes [Espagne] | What is the impact of education on Huntington's disease? |
| 000008 (2011) |
Angelo Antonini [Italie] ; Pablo Martinez-Martin [Espagne] ; Ray K. Chaudhuri [Royaume-Uni] ; Marcelo Merello [Argentine] ; Robert Hauser [États-Unis] ; Regina Katzenschlager [Autriche] ; Per Odin [Allemagne] ; Mark Stacy [États-Unis] ; Fabrizio Stocchi [Italie] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] | Wearing‐off scales in Parkinson's disease: Critique and recommendations |
| 000021 (2011) |
Mayela Rodríguez-Violante [Mexique] ; Andrew Lees (neurologue) [Royaume-Uni] ; Amin Cervantes-Arriaga [Mexique] ; Teresa Corona [Mexique] ; Laura Silveira-Moriyama [Royaume-Uni] | Use of smell test identification in Parkinson's disease in Mexico: A matched case‐control study |
| 000028 (2011) |
Niall P. Quinn [Royaume-Uni] ; Susanne A. Schneider [Royaume-Uni] ; Petra Schwingenschuh [Royaume-Uni, Autriche] ; Kailash P. Bhatia [Royaume-Uni] | Tremor—some controversial aspects |
| 000032 (2011) |
Elina Tripoliti [Royaume-Uni] ; Laura Strong [Royaume-Uni] ; Freya Hickey [Royaume-Uni] ; Tom Foltynie [Royaume-Uni] ; Ludvic Zrinzo [Royaume-Uni] ; Joseph Candelario [Royaume-Uni] ; Marwan Hariz [Royaume-Uni] ; Patricia Limousin [Royaume-Uni] | Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease |
| 000040 (2011) |
Nicola Z. Hobbs [Royaume-Uni] ; Amy V. Pedrick [Royaume-Uni] ; Miranda J. Say [Royaume-Uni] ; Chris Frost [Royaume-Uni] ; Rachelle Dar Santos [Canada] ; Allison Coleman [Canada] ; Aaron Sturrock [Canada] ; David Craufurd [Royaume-Uni] ; Julie C. Stout [Australie] ; Blair R. Leavitt [Canada] ; Josephine Barnes [Royaume-Uni] ; Sarah J. Tabrizi [Royaume-Uni] ; Rachael I. Scahill [Royaume-Uni] | The structural involvement of the cingulate cortex in premanifest and early Huntington's disease |
| 000048 (2011) |
Ashley H. Spencer [Royaume-Uni] ; Hugh Rickards [Royaume-Uni] ; Alfonso Fasano [Italie] ; Andrea E. Cavanna [Royaume-Uni] | The prevalence and clinical characteristics of punding in Parkinson's disease |
| 000052 (2011) |
Ji Klempí [République tchèque] ; Jana Židovská [République tchèque] ; Jan Štochl [Royaume-Uni] ; V Ra Kebrdlová Ing [République tchèque] ; Tereza Uhrová [République tchèque] ; Jan Roth [République tchèque] | The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease |
| 000054 (2011) |
Gerald Stern [Royaume-Uni] | The mother of all amine oxidases and the proposed father of amine oxidase inhibitors |
| 000061 (2011) |
Pablo Martinez-Martin [Espagne] ; Carmen Rodriguez-Blazquez [Espagne] ; Monica M. Kurtis [Espagne] ; K. Ray Chaudhuri [Royaume-Uni] | The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease |
| 000064 (2011) |
Sean S. O'Sullivan [Royaume-Uni] ; Mary Johnson [Royaume-Uni] ; David R. Williams [Australie] ; Tamas Revesz [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Elaine K. Perry [Royaume-Uni] | The effect of drug treatment on neurogenesis in Parkinson's disease |
| 000067 (2011) |
Joana Damásio [Royaume-Uni, Portugal] ; Mark J. Edwards [Royaume-Uni] ; Araceli Alonso-Canovas [Royaume-Uni, Espagne] ; Petra Schwingenschuh [Royaume-Uni, Autriche] ; Georg K Gi [Royaume-Uni, Suisse] ; Kailash P. Bhatia [Royaume-Uni] | The clinical syndrome of primary tic disorder associated with dystonia: A large clinical series and a review of the literature |
| 000070 (2011) |
Kailash P. Bhatia [Royaume-Uni] | The Wilson films — Wilson's disease |
| 000077 (2011) |
Susanne A. Schneider [Allemagne, Royaume-Uni] ; Peter G. Bain [Royaume-Uni] | The Wilson films — Bilateral postural tremor |
| 000079 (2011) |
Anne Pavy-Le Traon [France] ; Gerard Amarenco [France] ; Susanne Duerr [Autriche] ; Horacio Kaufmann [États-Unis] ; Heinz Lahrmann [Autriche] ; Stephanie R. Shaftman [États-Unis] ; François Tison [France] ; Gregor K. Wenning [Autriche] ; Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Olivier Rascol [France] | The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension |
| 000093 (2011) |
Stefan T. Schwarz [Royaume-Uni] ; Timothy Rittman [Royaume-Uni] ; Vamsi Gontu [Royaume-Uni] ; Paul S. Morgan [Royaume-Uni] ; Nin Bajaj [Royaume-Uni] ; Dorothee P. Auer [Royaume-Uni] | T1‐Weighted MRI shows stage‐dependent substantia nigra signal loss in Parkinson's disease |
| 000095 (2011) |
Christopher Kobylecki [Royaume-Uni] ; Michael P. Hill [Canada] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni, Canada] | Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease |
| 000098 (2011) |
Marwan I. Hariz [Royaume-Uni] | Surgical probings into the basal ganglia: Hemorrhage and hardware‐related risks, and costs of microelectrode recording |
| 000109 (2011) |
Philip A. Starr [États-Unis] ; Paul Bejjani [Liban] ; Andres M. Lozano [Canada] ; Leo Verhagen Metman [États-Unis] ; And Marwan I. Hariz [Royaume-Uni] | Stereotactic techniques and perioperative management of DBS in dystonia |
| 000115 (2011) |
Carl E. Clarke [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Caroline Rick [Royaume-Uni] ; Keith Wheatley [Royaume-Uni] ; Richard Gray [Royaume-Uni] | Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops? |
| 000129 (2011) |
Claudia Trenkwalder [Allemagne] ; Bryan Kies [Afrique du Sud] ; Monika Rudzinska [Pologne] ; Jennifer Fine [Afrique du Sud] ; Janos Nikl [Hongrie] ; Krystyna Honczarenko [Pologne] ; Peter Dioszeghy [Hongrie] ; Dennis Hill [États-Unis] ; Tim Anderson [Nouvelle-Zélande] ; Vilho Myllyla [Finlande] ; Jan Kassubek [Allemagne] ; Malcolm Steiger [Royaume-Uni] ; Marco Zucconi [Italie] ; Eduardo Tolosa [Espagne] ; Werner Poewe [Autriche] ; Erwin Surmann [Allemagne] ; John Whitesides [États-Unis] ; Babak Boroojerdi [Allemagne] ; Kallol Ray Chaudhuri [Royaume-Uni] ; the RECOVER Study Group [Allemagne, Afrique du Sud, Pologne, Hongrie, États-Unis, Nouvelle-Zélande, Finlande, Royaume-Uni, Italie, Espagne, Autriche] | Rotigotine effects on early morning motor function and sleep in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study (RECOVER) |
